Glassberg MK. Overview of idiopathic pulmonary fibrosis, evidence-based guidelines, and recent developments in the treatment landscape. Am J Manag Care. 2019;25:S195–S203.

PubMed  Google Scholar 

Yu G, Tzouvelekis A, Wang R, Herazo-Maya JD, Ibarra GH, Srivastava A, et al. Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function. Nat Med. 2018;24:39–49.

Article  CAS  PubMed  Google Scholar 

He Z, Zhu Y, Jiang H. Inhibiting toll-like receptor 4 signaling ameliorates pulmonary fibrosis during acute lung injury induced by lipopolysaccharide: an experimental study. Respir Res. 2009;10:126.

Article  PubMed  PubMed Central  Google Scholar 

Vancheri C, Crimi N, Conte E, Pistorio MP, Mastruzzo C, Lamicela M, et al. Human lung fibroblasts inhibit tumor necrosis factor-alpha production by LPS-activated monocytes. Am J Respir Cell Mol Biol. 1996;15:460–6.

Article  CAS  PubMed  Google Scholar 

Richeldi L, Cottin V, du Bois RM, Selman M, Kimura T, Bailes Z, et al. Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS((R)) trials. Respir Med. 2016;113:74–9.

Article  PubMed  Google Scholar 

Raghu G, Rochwerg B, Zhang Y, Garcia CA, Azuma A, Behr J, et al. An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. Am J Respir Crit Care Med. 2015;192:e3–19.

Article  PubMed  Google Scholar 

King TE Jr., Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2083–92.

Article  PubMed  Google Scholar 

John AE, Joseph C, Jenkins G, Tatler AL. COVID-19 and pulmonary fibrosis: a potential role for lung epithelial cells and fibroblasts. Immunol Rev. 2021;302:228–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu N, Li Z, Wang J, Geng L, Yue Y, Deng Z, et al. Low molecular weight fucoidan attenuating pulmonary fibrosis by relieving inflammatory reaction and progression of epithelial-mesenchymal transition. Carbohydr Polym. 2021;273:118567.

Article  CAS  PubMed  Google Scholar 

Lin X, Duan X, Liang YY, Su Y, Wrighton KH, Long J, et al. PPM1A functions as a Smad phosphatase to terminate TGFβ signaling. Cell. 2006;125:915–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang T, Wen F, Wu Y, Goh GS, Ge Z, Tan LP, et al. Cross-talk between TGF-beta/SMAD and integrin signaling pathways in regulating hypertrophy of mesenchymal stem cell chondrogenesis under deferral dynamic compression. Biomaterials. 2015;38:72–85.

Article  PubMed  Google Scholar 

Ye Z, Hu Y. TGF‑β1: Gentlemanly orchestrator in idiopathic pulmonary fibrosis (Review). Int J Mol Med. 2021;48:1–14.

Article  Google Scholar 

Martinez FJ, Collard HR, Pardo A, Raghu G, Richeldi L, Selman M, et al. Idiopathic pulmonary fibrosis. Nat Rev Dis Prim. 2017;3:17074.

Article  PubMed  Google Scholar 

Kolb M, Margetts PJ, Anthony DC, Pitossi F, Gauldie J. Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest. 2001;107:1529–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schroder K, Tschopp J. The inflammasomes. Cell. 2010;140:821–32.

Article  CAS  PubMed  Google Scholar 

Jiang W, Li M, He F, Zhou S, Zhu L. Targeting the NLRP3 inflammasome to attenuate spinal cord injury in mice. J Neuroinflamm. 2017;14:207.

Article  Google Scholar 

Lasithiotaki I, Giannarakis I, Tsitoura E, Samara KD, Margaritopoulos GA, Choulaki C, et al. NLRP3 inflammasome expression in idiopathic pulmonary fibrosis and rheumatoid lung. Eur Respir J. 2016;47:910–8.

Article  CAS  PubMed  Google Scholar 

Tang R, Wang YC, Mei X, Shi N, Sun C, Ran R, et al. LncRNA GAS5 attenuates fibroblast activation through inhibiting Smad3 signaling. Am J Physiol Cell Physiol. 2020;319:C105–C115.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Inman GJ, Nicolas FJ, Hill CS. Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity. Mol Cell. 2002;10:283–94.

Article  CAS  PubMed  Google Scholar 

Afonina IS, Zhong Z, Karin M, Beyaert R. Limiting inflammation-the negative regulation of NF-kappaB and the NLRP3 inflammasome. Nat Immunol. 2017;18:861–9.

Article  CAS  PubMed  Google Scholar 

Sun W, Yu Y, Dotti G, Shen T, Tan X, Savoldo B, et al. PPM1A and PPM1B act as IKKbeta phosphatases to terminate TNFalpha-induced IKKbeta-NF-kappaB activation. Cell Signal. 2009;21:95–102.

Article  CAS  PubMed  Google Scholar 

Evangelista S. Otilonium bromide: a selective spasmolytic for the gastrointestinal tract. J Int Med Res. 1999;27:207–22.

Article  CAS  PubMed  Google Scholar 

Wang L, Wang X, Chen J, Yang Z, Yu L, Hu L, et al. Activation of protein serine/threonine phosphatase PP2Cα efficiently prevents liver fibrosis. PLoS One. 2010;5:e14230.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Della Latta V, Cecchettini A, Del Ry S, Morales MA. Bleomycin in the setting of lung fibrosis induction: From biological mechanisms to counteractions. Pharmacol Res. 2015;97:122–30.

Article  PubMed  Google Scholar 

Xu J, Li W, Xu S, Gao W, Yu Z. Effect of dermatan sulphate on a C57-mouse model of pulmonary fibrosis. J Int Med Res. 2019;47:2655–65.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Inomata M, Kamio K, Azuma A, Matsuda K, Kokuho N, Miura Y, et al. Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis. Respir Res. 2014;15:16.

Article  PubMed  PubMed Central  Google Scholar 

Mecozzi L, Mambrini M, Ruscitti F, Ferrini E, Ciccimarra R, Ravanetti F, et al. In-vivo lung fibrosis staging in a bleomycin-mouse model: a new micro-CT guided densitometric approach. Sci Rep. 2020;10:18735.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park J, Jung J, Yoon SH, Hong H, Kim H, Kim H, et al. CT quantification of the heterogeneity of fibrosis boundaries in idiopathic pulmonary fibrosis. Eur Radio. 2021;31:5148–59.

Article  CAS  Google Scholar 

Lee HE, Myong JP, Kim HR, Rhee CK, Yoon HK, Koo JW. Incidence and prevalence of idiopathic interstitial pneumonia and idiopathic pulmonary fibrosis in Korea. Int J Tuberc Lung Dis. 2016;20:978–84.

Article  PubMed  Google Scholar 

Natsuizaka M, Chiba H, Kuronuma K, Otsuka M, Kudo K, Mori M, et al. Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences. Am J Respir Crit Care Med. 2014;190:773–9.

Article  PubMed  Google Scholar 

Zhao T, Wang J, He A, Wang S, Chen Y, Lu J, et al. Mebhydrolin ameliorates glucose homeostasis in type 2 diabetic mice by functioning as a selective FXR antagonist. Metabolism. 2021;119:154771.

Article  CAS  PubMed  Google Scholar 

Zhao T, Zhou Z, Zhao S, Wan H, Li H, Hou J, et al. Vincamine as an agonist of G protein-coupled receptor 40 effectively ameliorates pulmonary fibrosis in mice. Phytomedicine. 2023;118:154919.

Article